On Monday, 12th October, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) traded at $1.14. This indicated a 5 % decrease in the price of the previous day.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)- All You Need To Know
The previous close of the stock of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) was $1.2 and 1.87 was its beta. The price of the day varied between $1.1050 – 1.2000. The 12-month trailing PE ratio of the company is 0. Calculating the 52-week price range, the company has registered a high of $9.78 and a low of $1.04. In the past month, the stocks of the company made a profit of 39.36%.
The market capitalization of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is $95.47 million. On 6th August 2020, the company announced its quarterly earnings report. The company has a 0% forward dividend and 0 % yield. In such a situation, it is anticipated by the investors of the company that there may be a stock-loss. Analysts estimate that Corbus will report -$0.42 earnings per share (EPS). The estimated EPS growth has also come down to -$1.68 for the year 2020 and -$1.04 for 2021. The data suggests an EPS growth of 0.5% for 2020 and -0.38% for 2021.
On an average, short term indicators have placed the stock in 100% sell category. A 100% sell has been assigned by medium term indicators. Long term indicators have assigned 50% sell.
Stocks of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) have received a ‘strong buy’ rating from one analyst, a ‘strong sell’ rating from five analysts, a ‘hold’ rating from five analysts and a ‘buy’ rating from one analyst. No analysts have assigned the company a ‘sell’ rating. The average rating of the stock is ‘hold.’ This could be a golden opportunity for the investors to acquire stocks of the company.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)- Other Facts
The PEG ratio of the stocks of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is 0. -31.96% is the current level of price. The 50-day simple moving average of Corbus is -76.69%. 25.98 is the RSI (14). Over the past week, the volatility of the stock is recorded to be 11.59% and has lowered to 11.21% over the last 30 days. 1.87 is the beta value, 0.43 is the average true range (ATR) for the stocks. Over the next 12 months, the average target price on the company’s stock is $1.88, with estimates varying between $1.22 and $3. 7.02% and +163.16% are the price ends off the present level of price. If the price of Corbus’ shares reaches $1.65, the median price, investors can look forward to an exciting prospect of +44.74%.
